Subregional areal bone mineral density (aBMD) is a better predictor of heterogeneity in trabecular microstructure of vertebrae in young and aged women than subregional trabecular bone score (TBS) Germany, HR-pQCT, Microarchitecture, Osteoporosis, Serbia
Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties Diabetes, Germany, Review, Secondary osteoporosis
TBS as a tool to differentiate the impact of antiresorptives on cortical and trabecular bone in children with Osteogenesis imperfecta Denosumab, GE-Lunar, Germany, Longitudinal, Osteogenesis imperfecta, Pediatrics, Secondary osteoporosis, Treatment (anti-osteoporotic treatments)
Imaging of axial spondyloarthritis. New aspects and differential diagnoses Germany, Review, Rheumatology, Secondary osteoporosis, Spondyloarthritis
Trabecular bone score in type 1 diabetes–a cross-sectional study Diabetes, GE-Lunar, Germany, Secondary osteoporosis
A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX Australia, Canada, France, Germany, Japan, Meta-analysis, Osteoporosis, Sweden, Switzerland, TBS Osteo - All publications about FRAX, TBS-adjusted FRAX, UK
Effects of zoledronic acid versus placebo on bone mineral density and bone texture analysis assessed by the trabecular bone score in premenopausal women with breast cancer treatment-induced bone loss: results of the ProBONE II substudy. Aromatase inhibitor, Bisphosphonate, Breast cancer, GE-Lunar, Germany, Longitudinal, Secondary osteoporosis, Treatment (anti-osteoporotic treatments), Zoledronate
Effects of Exemestane and Tamoxifen treatment on bone texture analysis assessed by TBS in comparison with bone mineral density assessed by DXA in women with breast cancer Aromatase inhibitor, Breast cancer, Cancer, Exemestane, GE-Lunar, Germany, Longitudinal, Secondary osteoporosis, Tamoxifen, Treatment (anti-osteoporotic treatments)